KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 152 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $261,000 | +7.9% | 44,545 | -2.4% | 0.00% | – |
| Q3 2016 | $242,000 | -15.4% | 45,653 | +5.6% | 0.00% | – |
| Q2 2016 | $286,000 | +28.3% | 43,240 | -9.6% | 0.00% | – |
| Q1 2016 | $223,000 | -1.3% | 47,842 | +6.9% | 0.00% | – |
| Q4 2015 | $226,000 | -2.2% | 44,734 | -31.9% | 0.00% | – |
| Q3 2015 | $231,000 | -72.0% | 65,736 | -20.6% | 0.00% | -100.0% |
| Q2 2015 | $826,000 | +3.2% | 82,797 | +31.7% | 0.00% | 0.0% |
| Q1 2015 | $800,000 | +13.8% | 62,877 | +26.5% | 0.00% | 0.0% |
| Q4 2014 | $703,000 | -1.8% | 49,697 | -4.6% | 0.00% | 0.0% |
| Q3 2014 | $716,000 | -25.4% | 52,071 | -16.6% | 0.00% | 0.0% |
| Q2 2014 | $960,000 | -49.1% | 62,432 | -43.6% | 0.00% | -50.0% |
| Q1 2014 | $1,887,000 | +173.1% | 110,729 | +107.5% | 0.00% | +100.0% |
| Q4 2013 | $691,000 | +36.8% | 53,361 | +6.6% | 0.00% | 0.0% |
| Q3 2013 | $505,000 | -93.5% | 50,077 | -95.2% | 0.00% | -87.5% |
| Q2 2013 | $7,797,000 | – | 1,043,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 18,300,000 | $258,945,000 | 5.09% |
| EcoR1 Capital, LLC | 589,000 | $8,334,000 | 4.22% |
| Camber Capital Management LP | 3,000,000 | $42,450,000 | 2.82% |
| Cormorant Asset Management, LP | 1,000,000 | $14,150,000 | 2.18% |
| SECTORAL ASSET MANAGEMENT INC | 3,257,358 | $46,092,000 | 2.07% |
| Knoll Capital Management, LLC | 200,000 | $2,830,000 | 1.11% |
| OAK RIDGE INVESTMENTS LLC | 3,247,990 | $45,959,000 | 1.10% |
| NORTHPOINTE CAPITAL LLC | 514,445 | $7,279,000 | 0.87% |
| Apex Capital Management | 1,843,754 | $26,089,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,183,484 | $16,746,000 | 0.60% |